Jennifer D Brooks

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Cancer Causes Control 24:1605-14. 2013
  2. pmc Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 2nd Floor, New York 10065, USA
    Cancer Epidemiol Biomarkers Prev 21:2261-7. 2012
  3. pmc Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 84:917-24. 2012
  4. pmc Body mass index and risk of second primary breast cancer: the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Breast Cancer Res Treat 131:571-80. 2012
  5. pmc Promoter methylation and the detection of breast cancer
    Jennifer Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016 3240, USA
    Cancer Causes Control 20:1539-50. 2009
  6. pmc DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study
    Jennifer D Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, United States
    Cancer Epidemiol 34:717-23. 2010
  7. pmc Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Hum Mutat 33:158-64. 2012
  8. pmc Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study
    Anne S Reiner
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Clin Oncol 31:433-9. 2013
  9. doi request reprint Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI
    Valencia King
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
    Eur Radiol 22:2641-7. 2012
  10. doi request reprint Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging
    Valencia King
    Department of Radiology, Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Radiology 264:670-8. 2012

Detail Information

Publications14

  1. pmc Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Cancer Causes Control 24:1605-14. 2013
    ..The purpose of this study is to investigate the impact of germline genetic variation in genes coding for drug metabolizing enzymes, transporters, and targets on the association between chemotherapy and risk of CBC...
  2. pmc Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 2nd Floor, New York 10065, USA
    Cancer Epidemiol Biomarkers Prev 21:2261-7. 2012
    ..To explore the relationship between BMI and asynchronous contralateral breast cancer (CBC), we examined whether variants in genes related to obesity, weight, and weight change are associated with CBC risk...
  3. pmc Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 84:917-24. 2012
    ..Our study examined whether reproductive and hormonal factors before, at the time of, or after radiation treatment for a first primary breast cancer modify the risk of radiation-induced second primary breast cancer...
  4. pmc Body mass index and risk of second primary breast cancer: the WECARE Study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
    Breast Cancer Res Treat 131:571-80. 2012
    ..Our finding of an over five-fold higher risk of CBC in a small subgroup of obese postmenopausal women with an ER-negative first primary breast cancer is based on limited numbers and requires confirmation in a larger study...
  5. pmc Promoter methylation and the detection of breast cancer
    Jennifer Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016 3240, USA
    Cancer Causes Control 20:1539-50. 2009
    ..In general, studies in well-defined populations, including appropriate controls and larger numbers are needed. Further, focus on the optimization of methods of methylation detection in small amounts of DNA is needed...
  6. pmc DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study
    Jennifer D Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, United States
    Cancer Epidemiol 34:717-23. 2010
    ..This suggests the potential for these serum markers to be used for breast cancer detection...
  7. pmc Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
    Jennifer D Brooks
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Hum Mutat 33:158-64. 2012
    ..This suggests that carriers of this haplotype may be susceptible to the DNA-damaging effects of radiation therapy associated with radiation-induced breast cancer...
  8. pmc Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study
    Anne S Reiner
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Clin Oncol 31:433-9. 2013
    ..To fully characterize the risk of contralateral breast cancer (CBC) in patients with breast cancer with a family history who test negative for BRCA1 and BRCA2 mutations...
  9. doi request reprint Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI
    Valencia King
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
    Eur Radiol 22:2641-7. 2012
    ..To evaluate the effect of menopausal status on the background parenchymal enhancement (BPE) and amount of fibroglandular tissue (FGT) on breast MRI...
  10. doi request reprint Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging
    Valencia King
    Department of Radiology, Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Radiology 264:670-8. 2012
    ....
  11. doi request reprint Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy
    Janice S Sung
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States
    Eur J Radiol 82:1453-7. 2013
    ..To evaluate the safety and efficacy of pre-operative I-125 radioactive seed localization (RSL) as an alternative to wire localization (WL)...
  12. doi request reprint Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging
    Valencia King
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Breast J 18:527-34. 2012
    ..A significant association exists between treatment with tamoxifen and decreases in BPE, cysts, and FGT on breast MRI...
  13. doi request reprint Background parenchymal enhancement at breast MR imaging and breast cancer risk
    Valencia King
    Department of Radiology, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, 300 E 66th St, Room 715, New York, NY 10065, USA
    Radiology 260:50-60. 2011
    ..To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging...
  14. doi request reprint Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk
    Jennifer Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 17:1016-9. 2008